Huadong Medicine Co Ltd (000963)

Currency in CNY
43.01
+0.22(+0.51%)
Closed·
000963 Scorecard
Full Analysis
Prominent player in the Healthcare Providers & Services industry
000963 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.5043.37
52 wk Range
26.9646.00
Key Statistics
Bid/Ask
43.01 / 43.01
Prev. Close
43.01
Open
42.74
Day's Range
42.5-43.37
52 wk Range
26.96-46
Volume
9.39M
Average Volume (3m)
14.83M
1-Year Change
42.18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000963 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48.68
Upside
+13.19%
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments

Huadong Medicine Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Huadong Medicine Co Ltd Company Profile

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment. It also manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs; and engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides business, leasing, and warehousing services. The company has a strategic cooperation agreement with SynerK PharmaTech (Suzhou) Co., Ltd. to develop the small nucleic acid (siRNA) drug SNK-2726, an angiotensinogen (AGT) for the treatment of hypertension. Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

Employees
18265
Market
China

Compare 000963 to Peers and Sector

Metrics to compare
000963
Peers
Sector
Relationship
P/E Ratio
21.1x14.6x−0.5x
PEG Ratio
1.01−0.450.00
Price/Book
3.1x0.9x2.6x
Price / LTM Sales
1.8x0.4x3.3x
Upside (Analyst Target)
16.3%14.9%40.1%
Fair Value Upside
Unlock22.6%5.1%Unlock

Analyst Ratings

10 Buy
1 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 48.68
(+13.19% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.03%
Dividend Yield
2.16%
Industry Median 1.50%
Annualised payout
0.93
Paid unevenly
5-Years Growth
+27.14%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.52 / 0.565
Revenue / Forecast
10.74B / 11.63B
EPS Revisions
Last 90 days

000963 Income Statement

FAQ

What Stock Exchange Does Huadong Med A Trade On?

Huadong Med A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Huadong Med A?

The stock symbol for Huadong Med A is "000963."

What Is the Huadong Med A Market Cap?

As of today, Huadong Med A market cap is 75.26B.

What Is Huadong Med A's Earnings Per Share (TTM)?

The Huadong Med A EPS (TTM) is 2.03.

When Is the Next Huadong Med A Earnings Date?

Huadong Med A will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is 000963 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Huadong Med A Stock Split?

Huadong Med A has split 5 times.

How Many Employees Does Huadong Med A Have?

Huadong Med A has 18265 employees.

What is the current trading status of Huadong Med A (000963)?

As of 17 Aug 2025, Huadong Med A (000963) is trading at a price of 43.01, with a previous close of 43.01. The stock has fluctuated within a day range of 42.50 to 43.37, while its 52-week range spans from 26.96 to 46.00.

What Is Huadong Med A (000963) Price Target According to Analysts?

The average 12-month price target for Huadong Med A is CNY48.68444, with a high estimate of CNY54.05 and a low estimate of CNY41. 10 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +13.19% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.